Mpm Oncology Innovations Fund Lp - Net Worth and Insider Trading

Mpm Oncology Innovations Fund Lp Net Worth

The estimated net worth of Mpm Oncology Innovations Fund Lp is at least $88 Million dollars as of 2024-05-24. Mpm Oncology Innovations Fund Lp is the 10% Owner of Werewolf Therapeutics Inc and owns about 18,038,516 shares of Werewolf Therapeutics Inc (HOWL) stock worth over $88 Million. Details can be seen in Mpm Oncology Innovations Fund Lp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mpm Oncology Innovations Fund Lp has not made any transactions after 2021-05-04 and currently still holds the listed stock(s).

Transaction Summary of Mpm Oncology Innovations Fund Lp

To

Mpm Oncology Innovations Fund Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mpm Oncology Innovations Fund Lp owns 1 companies in total, including Werewolf Therapeutics Inc (HOWL) .

Click here to see the complete history of Mpm Oncology Innovations Fund Lp’s form 4 insider trades.

Insider Ownership Summary of Mpm Oncology Innovations Fund Lp

Ticker Comapny Transaction Date Type of Owner
HOWL Werewolf Therapeutics Inc 2021-05-04 10 percent owner

Mpm Oncology Innovations Fund Lp Latest Holdings Summary

Mpm Oncology Innovations Fund Lp currently owns a total of 1 stock. Mpm Oncology Innovations Fund Lp owns 18,038,516 shares of Werewolf Therapeutics Inc (HOWL) as of May 4, 2021, with a value of $88 Million.

Latest Holdings of Mpm Oncology Innovations Fund Lp

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HOWL Werewolf Therapeutics Inc 2021-05-04 18,038,516 4.88 88,027,958

Holding Weightings of Mpm Oncology Innovations Fund Lp


Mpm Oncology Innovations Fund Lp Form 4 Trading Tracker

According to the SEC Form 4 filings, Mpm Oncology Innovations Fund Lp has made a total of 1 transactions in Werewolf Therapeutics Inc (HOWL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Werewolf Therapeutics Inc is the acquisition of 245,000 shares on May 4, 2021, which cost Mpm Oncology Innovations Fund Lp around $4 Million.

Insider Trading History of Mpm Oncology Innovations Fund Lp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mpm Oncology Innovations Fund Lp Trading Performance

GuruFocus tracks the stock performance after each of Mpm Oncology Innovations Fund Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mpm Oncology Innovations Fund Lp is 0.94%. GuruFocus also compares Mpm Oncology Innovations Fund Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mpm Oncology Innovations Fund Lp within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Mpm Oncology Innovations Fund Lp's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Mpm Oncology Innovations Fund Lp

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -22.89
Relative Return to S&P 500(%) -24.46

Mpm Oncology Innovations Fund Lp Ownership Network

Ownership Network List of Mpm Oncology Innovations Fund Lp

No Data

Ownership Network Relation of Mpm Oncology Innovations Fund Lp


Mpm Oncology Innovations Fund Lp Owned Company Details

What does Werewolf Therapeutics Inc do?

Who are the key executives at Werewolf Therapeutics Inc?

Mpm Oncology Innovations Fund Lp is the 10 percent owner of Werewolf Therapeutics Inc. Other key executives at Werewolf Therapeutics Inc include director & 10 percent owner Ra Capital Healthcare Fund Lp , Chief Technology Officer Chulani Karunatilake , and Chief Operating Officer Reid Leonard .

Werewolf Therapeutics Inc (HOWL) Insider Trades Summary

Over the past 18 months, Mpm Oncology Innovations Fund Lp made no insider transaction in Werewolf Therapeutics Inc (HOWL). Other recent insider transactions involving Werewolf Therapeutics Inc (HOWL) include a net purchase of 1,853,000 shares made by Ra Capital Healthcare Fund Lp ,

In summary, during the past 3 months, insiders sold 0 shares of Werewolf Therapeutics Inc (HOWL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Werewolf Therapeutics Inc (HOWL) were sold and 1,853,000 shares were bought by its insiders, resulting in a net purchase of 1,853,000 shares.

Werewolf Therapeutics Inc (HOWL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Werewolf Therapeutics Inc Insider Transactions

No Available Data

Mpm Oncology Innovations Fund Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Mpm Oncology Innovations Fund Lp. You might contact Mpm Oncology Innovations Fund Lp via mailing address: 450 Kendall Street, Cambridge Ma 02142.

Discussions on Mpm Oncology Innovations Fund Lp

No discussions yet.